{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:09:17Z","timestamp":1789016957520,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002655","name":"Beckman Coulter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofliquidbiopsy.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Liquid Biopsy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jlb.2026.100478","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:48:10Z","timestamp":1782456490000},"page":"100478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sex hormone balance and PSA-derived biomarkers in cancer-free African migrant men in Italy: Implications for prostate cancer early detection"],"prefix":"10.1016","volume":"13","author":[{"given":"Felice","family":"Crocetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Fiorenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Perito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cennamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4296-429X","authenticated-orcid":false,"given":"Daniela","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jlb.2026.100478_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"10.1016\/j.jlb.2026.100478_bib2","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMoa2503223","article-title":"European study of prostate cancer screening - 23-year Follow-up","volume":"393","author":"Roobol","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jlb.2026.100478_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5534\/wjmh.210070","article-title":"Racial differences in prostate cancer characteristics and cancer-specific mortality: an overview","volume":"40","author":"Hinata","year":"2022","journal-title":"World J Mens Health"},{"issue":"1","key":"10.1016\/j.jlb.2026.100478_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MOU.0000000000000951","article-title":"Why do African-American men face higher risks for lethal prostate cancer?","volume":"32","author":"Nair","year":"2022","journal-title":"Curr Opin Urol"},{"issue":"17","key":"10.1016\/j.jlb.2026.100478_bib5","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1001\/jama.2019.2060","article-title":"Racial disparities in low-risk prostate cancer","volume":"321","author":"Ehdaie","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jlb.2026.100478_bib6","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1038\/s41467-023-43726-w","article-title":"Prostate cancer genetic risk and associated aggressive disease in men of African ancestry","volume":"14","author":"Soh","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jlb.2026.100478_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.eururo.2007.04.048","article-title":"Prostate cancer characteristics in a multiracial community","volume":"53","author":"Ravery","year":"2008","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.jlb.2026.100478_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.50416","article-title":"Evaluation of social determinants of health and prostate cancer outcomes among black and white patients: a systematic review and meta-analysis","volume":"6","author":"Vince","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"Suppl 1","key":"10.1016\/j.jlb.2026.100478_bib9","article-title":"Prostate cancer disparities in black men of African descent: a comparative literature review of prostate cancer burden among black men in the United States, Caribbean, United Kingdom, and West Africa","volume":"4","author":"Odedina","year":"2009","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"10.1016\/j.jlb.2026.100478_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00345-024-04905-6","article-title":"Evidence for clinically significant prostate cancer, overdiagnosis, active surveillance, and PSA screening","volume":"42","author":"Takahashi","year":"2024","journal-title":"World J Urol"},{"issue":"9","key":"10.1016\/j.jlb.2026.100478_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrurol.2013.169","article-title":"Prostate cancer: prostate health Index--improving screening in men with family history","volume":"10","author":"Loeb","year":"2013","journal-title":"Nat Rev Urol"},{"issue":"15","key":"10.1016\/j.jlb.2026.100478_bib12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/pros.70025","article-title":"Optimizing prostate cancer care: clinical utility of the prostate health index","volume":"85","author":"Lee","year":"2025","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.jlb.2026.100478_bib13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/JU.0000000000001453","article-title":"Performance of prostate health index in biopsy naive black men","volume":"205","author":"Babajide","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.jlb.2026.100478_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.urology.2022.12.057","article-title":"Re-thinking how we use prostate health index for African American men","volume":"175","author":"Morris","year":"2023","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.jlb.2026.100478_bib15","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDe2400065","article-title":"Reducing prostate cancer disparities for black men","volume":"3","author":"Hoffman","year":"2024","journal-title":"NEJM Evid"},{"issue":"7","key":"10.1016\/j.jlb.2026.100478_bib16","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1210\/jc.2007-0028","article-title":"Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans","volume":"92","author":"Rohrmann","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jlb.2026.100478_bib17","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/carcin\/bgt156","article-title":"High circulating estrogens and selective expression of ERbeta in prostate tumors of Americans: implications for racial disparity of prostate cancer","volume":"34","author":"Abd Elmageed","year":"2013","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.jlb.2026.100478_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.12.004","article-title":"Oestrogens and prostate cancer: novel concepts about an old issue","volume":"55","author":"Briganti","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.jlb.2026.100478_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fonc.2018.00002","article-title":"Estrogens and their receptors in prostate cancer: therapeutic implications","volume":"8","author":"Di Zazzo","year":"2018","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jlb.2026.100478_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pros.23446","article-title":"Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression","volume":"78","author":"Bonkhoff","year":"2018","journal-title":"Prostate"},{"issue":"9","key":"10.1016\/j.jlb.2026.100478_bib21","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/en.2012-1030","article-title":"Aggressive prostate cancer is prevented in ERalphaKO mice and stimulated in ERbetaKO TRAMP mice","volume":"153","author":"Slusarz","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.jlb.2026.100478_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trsl.2020.04.003","article-title":"Effects of estrogen receptor signaling on prostate cancer carcinogenesis","volume":"222","author":"Qu","year":"2020","journal-title":"Transl Res"},{"issue":"3","key":"10.1016\/j.jlb.2026.100478_bib23","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqag017","article-title":"Dysregulation of estrogen signaling and HSD17B7 in the prostate stroma of African American men","volume":"167","author":"Read","year":"2026","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jlb.2026.100478_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41419-025-07460-z","article-title":"Estrogen-related receptor alpha (ERRalpha) controls the stemness and cellular energetics of prostate cancer cells via its direct regulation of citrate metabolism and zinc transportation","volume":"16","author":"Ma","year":"2025","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.jlb.2026.100478_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.23736\/S2724-6051.24.05667-2","article-title":"Lower PHI, [-2]proPSA\/fPSA and testosterone\/estradiol ratios in healthy black men: preliminary results and potential implications in prostate cancer clinical management","volume":"77","author":"Ferro","year":"2025","journal-title":"Minerva Urol Nephrol"},{"key":"10.1016\/j.jlb.2026.100478_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2022.01.028","article-title":"Racial disparities in prostate cancer: a complex interplay between socioeconomic inequities and genomics","volume":"531","author":"Lowder","year":"2022","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.jlb.2026.100478_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2021.07.024","article-title":"Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European association of urology position and recommendations for 2021","volume":"80","author":"Van Poppel","year":"2021","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.jlb.2026.100478_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/iju.70409","article-title":"Clinical validation of the prostate health index for detecting clinically significant prostate cancer in a population-based screening program","volume":"33","author":"Yaegashi","year":"2026","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.jlb.2026.100478_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41391-023-00765-0","article-title":"Concerns regarding prostate cancer screening guidelines in minority populations","volume":"27","author":"Sweis","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.jlb.2026.100478_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/heapro\/daae129","article-title":"Inequalities in health literacy between European population and newly arrived male sub-saharan migrants in Europe","volume":"39","author":"Ferreira-Alfaya","year":"2024","journal-title":"Health Promot Int"},{"issue":"12","key":"10.1016\/j.jlb.2026.100478_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0315288","article-title":"The PROCAN-B study protocol: early diagnosis of PROstate CANcer for black men-a community-centred participatory approach in Scotland and the North-East of England","volume":"19","author":"Christie-de Jong","year":"2024","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jlb.2026.100478_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-105803","article-title":"A mixed-methods evaluation of a peer-led, co-produced, asset-based intervention for early diagnosis of prostate cancer for Black men: the PROCAN-B study","volume":"15","author":"Christie-de Jong","year":"2025","journal-title":"BMJ Open"}],"container-title":["The Journal of Liquid Biopsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295019542600024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295019542600024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:30:08Z","timestamp":1789014608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S295019542600024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S295019542600024X"],"URL":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100478","relation":{},"ISSN":["2950-1954"],"issn-type":[{"value":"2950-1954","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex hormone balance and PSA-derived biomarkers in cancer-free African migrant men in Italy: Implications for prostate cancer early detection","name":"articletitle","label":"Article Title"},{"value":"The Journal of Liquid Biopsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The International Society of Liquid Biopsy.","name":"copyright","label":"Copyright"}],"article-number":"100478"}}